Position in NVS
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$6,353,742
+$48,070 QoQ
Shares Held
40,542
-1.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#229
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DAVENPORT & Co LLC holds $494,810,441 across 13 Drug Manufacturers - General names. NVS ranks #9 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
862,394 | $219,022,204 | |
| 2 | SNY |
Sanofi
|
2,001,451 | $85,381,899 | |
| 3 | LLY |
ELI LILLY & Co
|
40,627 | $48,729,246 | |
| 4 | ABBV |
AbbVie Inc.
|
191,426 | $48,170,438 | |
| 5 | MRK |
Merck & Co., Inc.
|
271,897 | $34,938,764 | |
| 6 | AMGN |
Amgen Inc
|
57,790 | $20,926,914 | |
| 7 | PFE |
Pfizer Inc
|
446,366 | $10,748,493 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
120,870 | $6,964,529 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,353,742 | 40,542 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $6,305,672 | 41,281 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $5,151,374 | 37,364 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $5,390,696 | 42,036 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $4,075,979 | 33,683 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $3,447,519 | 30,925 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $3,178,144 | 32,660 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,885,145 | 33,778 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $3,672,124 | 34,493 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $3,322,191 | 34,345 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $3,246,690 | 32,155 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $3,374,418 | 33,128 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $3,754,659 | 37,208 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $3,736,580 | 40,615 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $3,366,709 | 37,111 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,867,629 | 37,727 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $2,760,580 | 32,658 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $2,935,500 | 33,453 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,888,259 | 33,020 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,892,149 | 35,365 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,375,534 | 15,076 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $1,238,177 | 14,485 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $983,677 | 10,417 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $854,816 | 9,830 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $867,810 | 9,936 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $835,713 | 10,136 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||